Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 12Breast Neoplasms 10Lung Neoplasms 9Neoplasms 8Uterine Cervical Neoplasms 7Colonic Neoplasms 5Hematopoietic and Lymphatic System Neoplasm 4Papillomavirus Infections 3Liver Neoplasms 3Carcinoma, Hepatocellular 3Rectal Neoplasms 2Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Patient Compliance 2Neoplasm Metastasis 2Hematologic Neoplasms 2Colorectal Cancer Screening 2Tobacco Use 1Smoking 1Pyloric Stenosis, Hypertrophic 1Psychological Well-Being 1Overweight 1Obesity 1Multiple Myeloma 1Multiple Endocrine Neoplasia Type 1 1Lymphoma 1Liver Diseases 1Hypertension 1Hepatitis C 1Head and Neck Neoplasms 1

Interventions

Rapid Diagnostic Tests 1Patient Navigation 1Mass Screening 1Hypothermia, Induced 1Enzyme-Linked Immunosorbent Assay 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Hepatitis C × Patient Navigation × Clear all
NCT02833298 2018-10-12

Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening

Icahn School of Medicine at Mount Sinai

Phase NA Completed
25 enrolled
Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡